NO20002176D0 - Diagnostikk og terapi av kronisk obstruktiv luftveissykdom - Google Patents

Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Info

Publication number
NO20002176D0
NO20002176D0 NO20002176A NO20002176A NO20002176D0 NO 20002176 D0 NO20002176 D0 NO 20002176D0 NO 20002176 A NO20002176 A NO 20002176A NO 20002176 A NO20002176 A NO 20002176A NO 20002176 D0 NO20002176 D0 NO 20002176D0
Authority
NO
Norway
Prior art keywords
chronic obstructive
diagnosis
therapy
obstructive airway
airway disease
Prior art date
Application number
NO20002176A
Other languages
English (en)
Other versions
NO20002176L (no
Inventor
Gordon W Duff
Marco Giovine
Peter J Barnes
Simon Lim
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9723553.5A external-priority patent/GB9723553D0/en
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Publication of NO20002176D0 publication Critical patent/NO20002176D0/no
Publication of NO20002176L publication Critical patent/NO20002176L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002176A 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom NO20002176L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9723553.5A GB9723553D0 (en) 1997-11-07 1997-11-07 Prediction of the risk of chronic obstructive airway disease
US09/005,923 US6140047A (en) 1997-11-07 1998-01-12 Method and kit for predicting susceptibility to asthma
PCT/US1998/023721 WO1999024615A2 (en) 1997-11-07 1998-11-09 Diagnostics and therapeutics for chronic obstructive airway disease

Publications (2)

Publication Number Publication Date
NO20002176D0 true NO20002176D0 (no) 2000-04-27
NO20002176L NO20002176L (no) 2000-07-05

Family

ID=26312564

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002176A NO20002176L (no) 1997-11-07 2000-04-27 Diagnostikk og terapi av kronisk obstruktiv luftveissykdom

Country Status (13)

Country Link
EP (1) EP1029079B1 (no)
JP (1) JP2001522586A (no)
AT (1) ATE383438T1 (no)
AU (1) AU760856B2 (no)
BR (1) BR9813950A (no)
CA (1) CA2308570A1 (no)
ES (1) ES2297900T3 (no)
HU (1) HUP0301197A2 (no)
IL (1) IL135957A0 (no)
NO (1) NO20002176L (no)
PL (1) PL340624A1 (no)
TR (1) TR200001263T2 (no)
WO (1) WO1999024615A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
EP1192275A2 (en) * 1999-04-02 2002-04-03 Interleukin Genetics, Inc. Prediction of risk of interstitial lung disease
AU7706000A (en) * 1999-09-22 2001-04-24 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the interleukin-1 beta gene
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US20050159590A1 (en) * 2003-08-25 2005-07-21 Galit Rotman Variants of interleukin-1 receptor antagonist: compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001997A1 (en) * 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease

Also Published As

Publication number Publication date
JP2001522586A (ja) 2001-11-20
NO20002176L (no) 2000-07-05
ES2297900T3 (es) 2008-05-01
WO1999024615A2 (en) 1999-05-20
EP1029079A2 (en) 2000-08-23
ATE383438T1 (de) 2008-01-15
AU1386399A (en) 1999-05-31
IL135957A0 (en) 2001-05-20
PL340624A1 (en) 2001-02-12
CA2308570A1 (en) 1999-05-20
AU760856B2 (en) 2003-05-22
EP1029079B1 (en) 2008-01-09
HUP0301197A2 (hu) 2003-07-28
TR200001263T2 (tr) 2000-12-21
WO1999024615A3 (en) 1999-09-16
BR9813950A (pt) 2000-09-26

Similar Documents

Publication Publication Date Title
WO2000037679A3 (en) Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis
NO980439L (no) Detektering av genetisk predisposisjon for periodontal sykdom
DE69333461D1 (de) VERFAHREN ZUM nachweis der Alzheimer Krankheit
ATE462710T1 (de) Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
NO20003853D0 (no) Forbindelser for terapi og diagnose av lungekreft og metoder for deres anvendelse
NO995690D0 (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
WO2001000880A3 (en) Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
EP0883809A4 (en) METHOD FOR DIAGNOSTIC PROSTATE ADENOCARCINOMAS
DK0760010T3 (da) Fremgangsmåder til screening for Crohn's sygdom under anvendelse af TNF-mikrosatellit-alleler
NO20002176D0 (no) Diagnostikk og terapi av kronisk obstruktiv luftveissykdom
ATE476662T1 (de) Diagnoseverfahren
FI952767L (fi) Väline antrum- ja korpuskoepalojen yhdistetyn ureaasitestin tekemiseksi maha- ja suolistosairauksien diagnosointia varten
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE221200T1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
BR0010558A (pt) Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico
NO985280D0 (no) Anvendelse av en mutasjon i genet for human G-protein 3 subenhet for diagnostisering av sykdommer
SG164275A1 (en) Methods, compositions and kits relating to cardiovascular disease
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
FI974064A7 (fi) Menetelmät ja testipakkaukset parodontaalisairauksien diagnostisoimise ksi ja niiden etenemisriskin ennustamiseksi
NO974679L (no) Fremgangsmåte og forsökssett for diagnostikk av periodontale sykdommer og for bestemmelse av risiko for progresjon derav
RU96102356A (ru) Способ выявления сердечной недостаточности в клинической практике у больных с гипертрофической кардиомиопатией
ITCT940005A1 (it) Terapia dei tumori fondata sull'impiego di enzimi
FR2738576B1 (fr) Anticorps specifiques de la 5 alpha reductase, kit de diagnostic, et procede de production des anticorps
KR960005397U (ko) 터널의 천단침하검측용 스타프의 궤가장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application